3. Menstruation
Shedding the uterine lining
(endometrium) if pregnancy does not
occur.
Necessary (in the absence of
hormonal regulation) to insure the
endometrium does not become
hyperplastic.
4. Normal Menstrual
Cycles
Mature, ovulatory women
– 28-29 day average
– 21-36 day range
– 2-7 days duration
– 20-80 cc of blood loss per month
5. Cycle Variation
Women in their middle reproductive
years have the most predictable cycles
More pronounced cycle to cycle
variability in the 5-7 years after
menarche and 6-8 years before
menopause
6. Cycle Variation (cont.)
Adolescents
– Majority range 21-48 days
– Usually anovulatory
– Mean time from menarche until half the cycles
are ovulatory depends upon the age of
menarche
– 12 yrs 1yrs till half cycles are ovulatory
– 12-13 3yrs
– >13 4.5 yrs
7. Cycle Variation (cont.)
Perimenopause
– Cycles initially shorten
– Ultimately (apparently) lengthen, as an
entire cycle will be skipped
Average age of menopause is 51
– Cessation of menses for one year
10. Terminology
Amenorrhea—lack of menstrual bleeding
– Primary—no menses by age 16
– Secondary—absence of 3 or more expected
menstrual cycles
Break-through bleeding (BTB) unexpected
bleeding usually occurring while a woman is
on exogenous hormonal medication (eg
OCPs, patch, or ring)
11. Terminology (cont.)
Menorrhagia—heavy menstrual bleeding.
Prolonged or excessive menstrual blood
loss with regular cycles
Metrorrhagia—irregular, frequent bleeding
Menometrorrhagia—irregular menses with
prolonged or excessive blood loss
Midcycle bleeding—light menstrual
bleeding occurring in ovulatory women at
the midcycle estradiol trough
12. Terminology (cont.)
Oligomenorrhea-- menstrual
bleeding/menses occurring less frequently
than 36 days apart
Polymenorrhea—frequent menstrual
bleeding/menses occurring more frequently
than 21 days apart
Contact bleeding/post-coital bleeding
Dysmenorrhea- painful menstrual bleeding
13. Impact on Health
75% of women experience physical changes
associated with menses
PMS (Premenstrual syndrome)
PMDD (Premenstrual dysphoric disorder)
Direct and indirect health care costs
– Visits to ED, clinic, or office
– Time lost from work
14. PMS
Psychoneuroendocrine d/o with
biological, social and psychological
impacts
Up to 75% of women experience some
level of recurrent sx
Up to 5% may experience severe sx
and distress
15. Common PMS
Symptoms
Headache
Breast pain
Bloating
Irritability
Fatigue
Crying
Abd pain
Clumsiness
Sleep alteration
Labile mood
Social withdrawal
Libido change
Appetite change
16. Requisite Symptoms
for PMDD Diagnosis
Depressed mood
Anxiety/tension
Mood swings
Irritability
Decreased interest
Concentration
difficulties
Fatigue
Appetite changes/food
cravings
Insomnia/hypersomnia
Feeling out of control
Physical symptoms
5/11 symptoms
needed for
diagnosis and
Sx disrupt daily
functioning
18. Dysmenorrhea
Painful menstruation- when pain
prevents normal activity and requires
medication
Pain starts when bleeding starts
Prostaglandin activity
Emotional/psychological factors
19. Dysmenorrhea tx
NSAIDs, starting a day before period
– Ibuprofen, naproxen
Anti-prostaglandins much less
effective after pain is established
Continuous heat to abd
OCPs for 6-12 months have lasting
benefit
20. Ddx of Abnormal
Uterine Bleeding
Blood Dyscrasias
Anatomic causes of bleeding,
including pregnancy
Anovulation
Malignancy
Non-uterine causes of bleeding
21. AUB work-up
Hx
PE with cytology
Pelvic ultrasound
Endometrial biopsy
Hysteroscopy
D & C
22.
23.
24. Leiomyomas (Fibroids)
Benign neoplasms arising from uterine wall
smooth muscle cells
20-25% of reproductive age women
Can be small to quite large, single or
multiple. Surrounded by pseudocapsule.
Often asx, but can cause metrorrhagia,
menorrhagia, dysmenorrhea and infertility
Cause unknown, but hormone responsive
25. Fibroid Tx
Depends on sx, age, parity,
reproductive plans, general health,
and size/location of leiomyomas
GnRH agonists- to shrink fibroid
OCPs control bleeding but do not treat
the fibroid
Progestin-releasing IUD for multiple
small leiomyomata
26. Fibroid Tx - Surgical
Myomectomy- preserves fertility, high risk
for fibroid recurrence
Hysterectomy- eliminates sx and chance of
recurrence. Also eliminates uterus.
Uterine fibroid embolization (UFE)
– Embolic occlusion of uterine arteries
– As effective as above, few recurrences, few
major complications
27. Anovulation
Patient History—very important to
diagnosis
– Ovulatory cycles—consistent number of
days from beginning of one cycle to the
next, breast tenderness, and
dysmenorrhea usually present
– Anovulatory cycles—variation in
number of days per cycle, no breast
tenderness, and dysmenorrhea is not
consistent from one cycle to the next
28. DUB
“Dysfunctional uterine bleeding”
Abnormal uterine bleeding with
pathologic causes ruled out
So..you’ve done all that stuff, and it’s
all okay
Usually tx with hormones (ie OCPs) to
control bleeding
29. Non-uterine causes
Genital neoplasms of the vulva or vagina
– To avoid missing vaginal lesions, stainless steel
speculum blades should be rotated on removal
to fully evaluate the vaginal mucosa
– Better: use plastic speculum with good light
source
Genital trauma/foreign objects
Rectal bleeding or urinary tract source
30. Evaluation
History
– Menstrual pattern (duration, changes in
quality, color of menses)
– Dysmenorrhea, mittleschmerz, breast
changes
– Post-coital spotting
– Dietary practices, change in weight,
exercise, stress
– Evidence of systemic disease
31. Evaluation (cont.)
Physical Exam
– Vital signs, height, weight, body phenotype, BMI
– Skin, hair (acne, hirsutism pattern)
– Fat distribution, striae
– Thyroid
– Breast exam to check for galactorrhea
– Complete pelvic exam
– Tanner stage for teens
32. Evaluation--testing
All patients:
– Pregnancy test
– CBC with platelets
– Recent Pap
Over 35 yrs:
– Endometrial sample
Documented drop in
hgb <10
– PT, PTT
– Bleeding time
As indicated:
– TSH
– Prolactin
– Testosterone
– LH/FSH
– 17-OH progesterone
– Overnight
dexamethasone
suppression test or 24
hr urinary free cortisol
– Hysteroscopy or
ultrasound
33. Acute Bleeding: Control
Oral progestins:
– Micronized Progesterone 200 mg (Prometrium)
or Medroxyprogesterone 10 mg (Provera) or
Norethindrone 5 mg (Aygestin)
– 1 po q4 hrs or until bleeding stops, then
– 1 qid x 4 days
– 1 tid x 3 days
– 1 bid x 2 weeks, then
– Cycle monthly with progestin or low dose oral
contraceptive
34. AUB Long Term Control
Cycle with low dose OCP, patch, or vaginal
ring
Cycle with a progestin, eg Prometrium
Use of progestin-containing IUD (Mirena)
Choice depends upon:
– Contraceptive need
– Smoking status
– Medical history
– Patient preference
35. Endometriosis
Abnormal growth of endometrial tissue
in locations other than the uterine
lining
3-10% of women of reproductive age
30% of infertile women
36.
37.
38. Tx
Analgesics (ibu)
Hormones
– OCPs or progestins
– Danazol- prevents gonadotropin release, inhibits
midcyle LH and GSH. Androgenic side fx
– GnRH agonists (Lupron)- with continuous admin,
suppresses gonadotropin secretion
Assisted reproduction when desired
39. Amenorrhea
Absence of menses
Primary amenorrhea- no menses by age 16
with otherwise nl development
Secondary amenorrhea- absence of
menses for 3 or more cycles or 6 months in
a previously menstruating female
– MC cause??
– 3% in genl population
– 100% under extreme stress
Examples?
40. Tx
Desiring pregnancy?
– Ovulation induction
Not desiring pregnancy?
– If hypoestrogenic, combo tx with estrogen and
progesterone to maintain bone density and
prevent genital atrophy
– Normal progestin challenge: needs occasional
progestin to prevent endometrial hyperplasia and
cancer
– OCPs work well for either, and can decrease
hirsutism
– Calcium, too!